RJ

Roger J. Hajjar

Cardiovascular Research Center, Mount Sinai School of Medicine

Affiliated withMount Sinai School of Medicine

Research Area

Biography

Roger J. Hajjar has not added Biography.
If you are Roger J. Hajjar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3
Year
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Publication title

Cited by 21

2011
2020
2019

Other Publications

Article
Year
Targeting phospholamban by gene transfer in human heart failure.

Circulation| PubMed ID: 11864915

2002
2002
Functional consequences of caspase activation in cardiac myocytes.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 11972044

2002
2002
Type 1 phosphatase, a negative regulator of cardiac function.

Molecular and cellular biology| PubMed ID: 12024026

2002
2002
2002
2002
Adrenergic-receptor polymorphisms and heart failure.

The New England journal of medicine| PubMed ID: 12374881

2002
Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 12388307

2002
2002
Myofibrillar responsiveness to cAMP, PKA, and caffeine in an animal model of heart failure.

Biochemical and biophysical research communications| PubMed ID: 12504124

2003
2003
2002
Efficient viral gene transfer to rodent hearts in vivo.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 12597008

2003
2003
Targeting signaling pathways in heart failure by gene transfer.

Current atherosclerosis reports| PubMed ID: 12667429

2003
Genetic editing of dysfunctional myocardium.

The Medical clinics of North America| PubMed ID: 12693739

2003
2003
2002
Gene therapy for the treatment of heart failure--calcium signaling.

Seminars in thoracic and cardiovascular surgery| PubMed ID: 12973704

2003
Apoptosis in heart failure and the senescent heart.

Cardiovascular toxicology| PubMed ID: 14555785

2003
Damped elastic recoil of the titin spring in myofibrils of human myocardium.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 14563922

2003
2003
Titin--springing back to youth?

Science of aging knowledge environment : SAGE KE| PubMed ID: 14603021

2002
2008
Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 15044708

2004
Gene transfer in cardiac myocytes.

The Surgical clinics of North America| PubMed ID: 15053187

2004
2004
Transcriptional changes following restoration of SERCA2a levels in failing rat hearts.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 15247151

2004
2004
Antisense strategies for treatment of heart failure.

Methods in molecular medicine| PubMed ID: 15375313

2005
Targeted gene transfer in heart failure: implications for novel gene identification.

Current opinion in molecular therapeutics| PubMed ID: 15468597

2004
2004
2004
2004
2005
Mesenchymal stem cells in the infarcted heart.

Coronary artery disease| PubMed ID: 15735401

2005
2005
2005
2005
Catheter-based ventricle-coronary vein bypass.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions| PubMed ID: 15822113

2005
2005
Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 15897329

2005
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 16055523

2006
2005
2005
Tracking stem cells in the cardiovascular system.

Trends in cardiovascular medicine| PubMed ID: 16297767

2005
Magnetic resonance assessment of myocardial perfusion via catheter-based ventricle-coronary vein bypass in porcine myocardial infarction model.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions| PubMed ID: 16345049

2006
Gene and cell therapy in heart failure.

Le Journal médical libanais. The Lebanese medical journal| PubMed ID: 16398210

2005
2006
Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 16503203

2006
SERCA2a in heart failure: role and therapeutic prospects.

Journal of bioenergetics and biomembranes| PubMed ID: 16691468

2005
2006
Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 16997893

2007
CXCR4 modulates contractility in adult cardiac myocytes.

Journal of molecular and cellular cardiology| PubMed ID: 17010372

2006
2007
2007
2007
2007
Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 17220178

2007
2007
2007
2007
2007
2005
Targeting genes and cells in the progression to heart failure.

Heart failure clinics| PubMed ID: 17386853

2005
Gene therapy in the treatment of heart failure.

Physiology (Bethesda, Md.)| PubMed ID: 17420300

2007
In vivo tracking in cardiac stem cell-based therapy.

Progress in cardiovascular diseases| PubMed ID: 17498521

2007
2007
2007
Preservation of mechanical and energetic function after adenoviral gene transfer in normal rat hearts.

Clinical and experimental pharmacology & physiology| PubMed ID: 17973872

2007
2007
2008
2008
2008
2008
2008
Progressive nature of chronic mitral regurgitation and the role of tissue Doppler-derived indexes.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 18326805

2008
Fingerprint profile of alcohol-associated heart failure in human hearts.

Alcoholism, clinical and experimental research| PubMed ID: 18336640

2008
Intracellular devastation in heart failure.

Heart failure reviews| PubMed ID: 18347978

2008
Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine| PubMed ID: 18483105

2008
2008
Role of resistin in cardiac contractility and hypertrophy.

Journal of molecular and cellular cardiology| PubMed ID: 18597775

2008
Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells.

Nature clinical practice. Cardiovascular medicine| PubMed ID: 18641613

2008
2008
2008
Ventricular arrhythmias after left ventricular assist device implantation.

Pacing and clinical electrophysiology : PACE| PubMed ID: 18811803

2008
2008
PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility.

Journal of molecular and cellular cardiology| PubMed ID: 18929570

2008
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 19074672

2009
Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 19201995

2009
2009
The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling.

Journal of molecular and cellular cardiology| PubMed ID: 19272299

2009
2009
2009
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.

Expert opinion on drug metabolism & toxicology| PubMed ID: 19442031

2009
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.

Journal of molecular and cellular cardiology| PubMed ID: 19481088

2009
2009
2009
2007
Mechanoelectrical remodeling and arrhythmias during progression of hypertrophy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 19825979

2010
2009
Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.

Expert opinion on biological therapy| PubMed ID: 20078230

2010
2010
2010
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.

Journal of molecular and cellular cardiology| PubMed ID: 20430035

2010
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 20461063

2010
2010
Advances in gene-based therapy for heart failure.

Journal of cardiovascular translational research| PubMed ID: 20559907

2008
2010
2010
2010
2010
2010
Multimodality imaging of chronic ischemia.

Cardiology research and practice| PubMed ID: 20981290

2010
Gene therapy for heart failure.

Archives of cardiovascular diseases| PubMed ID: 21074127

2010
Cardiac gene therapy.

Seminars in thoracic and cardiovascular surgery| PubMed ID: 21092890

2010
Cardiac gene therapy with SERCA2a: from bench to bedside.

Journal of molecular and cellular cardiology| PubMed ID: 21093451

2011
2011
Refilling Intracellular Calcium Stores.

Drug discovery today. Disease mechanisms| PubMed ID: 21170146

2010
Method of gene delivery in large animal models of cardiovascular diseases.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 21194040

2011
2011
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle.

The Journal of clinical investigation| PubMed ID: 21285509

2011
Rescuing the failing heart by targeted gene transfer.

Journal of the American College of Cardiology| PubMed ID: 21371634

2011
2011
2011
2011
2011
2011
Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats.

Journal of molecular and cellular cardiology| PubMed ID: 21549710

2011

American journal of physiology. Heart and circulatory physiology| PubMed ID: 21551276

2011
Targeted gene therapy for the treatment of heart failure.

The Canadian journal of cardiology| PubMed ID: 21601767

2011
A new model of congestive heart failure in rats.

American journal of physiology. Heart and circulatory physiology| PubMed ID: 21685270

2011
2011
AKT signalling in the failing heart.

European journal of heart failure| PubMed ID: 21724622

2011
2011
2011
2011
Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 21915102

2012
Gene delivery methods in cardiac gene therapy.

The journal of gene medicine| PubMed ID: 21954037

2011
2011
2011
2011
Cardiac gene therapy: from concept to reality.

Current heart failure reports| PubMed ID: 22143928

2012
Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.

Journal of molecular and cellular cardiology| PubMed ID: 22197309

2011
Concomitant Intravenous Nitroglycerin With Intracoronary Delivery of AAV1.SERCA2a Enhances Gene Transfer in Porcine Hearts.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 22215018

2012
2012
Tracking cell therapy: bioluminescence lighting the way.

JACC. Cardiovascular imaging| PubMed ID: 22239893

2012
2012